By reducing STAT3 and HIF-1α levels, sulforaphane also diminishes VEGF expression, exerting anti-angiogenic effects in hepatocellular carcinoma [45] (Figure 1 and Table 1). This evidence concerns the gene STAT3 and hepatocellular carcinoma.